Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Literature DB >> 19775690

The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Shiri Kalet-Litman, Pedro R Moreno, Andrew P Levy.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19775690 PMCID： PMC2830328 DOI： 10.1016/j.atherosclerosis.2009.09.002

Source DB: PubMed Journal: Atherosclerosis ISSN： 0021-9150 Impact factor: 5.162

× No keyword cloud information.

17 in total

1. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors: Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal: J Am Coll Cardiol Date: 2002-12-04 Impact factor: 24.094

Review 2. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation.

Authors: B H Bowman; A Kurosky
Journal: Adv Hum Genet Date: 1982

3. Hemoglobin: a mechanism for the generation of hydroxyl radicals.

Authors: B R Van Dyke; P Saltman
Journal: Free Radic Biol Med Date: 1996 Impact factor: 7.376

4. Identification of the haemoglobin scavenger receptor.

Authors: M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal: Nature Date: 2001-01-11 Impact factor: 49.962

5. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

Authors: Uzi Milman; Shany Blum; Chen Shapira; Doron Aronson; Rachel Miller-Lotan; Yefim Anbinder; Junia Alshiek; Lawrence Bennett; Maria Kostenko; Michele Landau; Shlomo Keidar; Yishai Levy; Alexander Khemlin; Arman Radan; Andrew P Levy
Journal: Arterioscler Thromb Vasc Biol Date: 2007-11-21 Impact factor: 8.311

6. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.

Authors: Ariel Roguin; Werner Koch; Adnan Kastrati; Doron Aronson; Albert Schomig; Andrew P Levy
Journal: Diabetes Care Date: 2003-09 Impact factor: 19.112

7. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.

Authors: Rabea Asleh; Stuart Marsh; Mark Shilkrut; Ofer Binah; Julia Guetta; Flavio Lejbkowicz; Ben Enav; Naim Shehadeh; Yoram Kanter; Orit Lache; Osher Cohen; Nina S Levy; Andrew P Levy
Journal: Circ Res Date: 2003-05-15 Impact factor: 17.367

8. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.

Authors: Tina Costacou; Robert E Ferrell; Trevor J Orchard
Journal: Diabetes Date: 2008-03-10 Impact factor: 9.461

9. Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.

Authors: Pedro R Moreno; K Raman Purushothaman; Meera Purushothaman; Paul Muntner; Nina S Levy; Valentin Fuster; John T Fallon; Patrick A Lento; Aaron Winterstern; Andrew P Levy
Journal: J Am Coll Cardiol Date: 2008-09-23 Impact factor: 24.094

10. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.

Authors: Vladimir V Bamm; Vladimir A Tsemakhovich; Matityahu Shaklai; Nurith Shaklai
Journal: Biochemistry Date: 2004-04-06 Impact factor: 3.162

13 in total

Review 1. Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.

Authors: Yury I Miller; Sotirios Tsimikas
Journal: Curr Opin Lipidol Date: 2013-10 Impact factor: 4.776

Review 2. Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors: Tina Costacou; Andrew P Levy
Journal: J Cardiovasc Transl Res Date: 2012-03-24 Impact factor: 4.132

Review 3. The genetics of vascular complications in diabetes mellitus.

Authors: Dan Farbstein; Andrew P Levy
Journal: Cardiol Clin Date: 2010-08 Impact factor: 2.213

4. Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors: Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal: J Biol Chem Date: 2014-04-28 Impact factor: 5.157

5. Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.

Authors: Jenna L Leclerc; Spiros Blackburn; Dan Neal; Nicholas V Mendez; Jeffrey A Wharton; Michael F Waters; Sylvain Doré
Journal: Proc Natl Acad Sci U S A Date: 2015-01-12 Impact factor: 11.205

6. Haptoglobin genotype and the iron hypothesis of atherosclerosis.

Authors: Hilla Lee Viener; Andrew P Levy
Journal: Atherosclerosis Date: 2011-01-28 Impact factor: 5.162

7. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.

Authors: Niyati U Mehta; Victor Grijalva; Susan Hama; Alan Wagner; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal: Arterioscler Thromb Vasc Biol Date: 2016-04-14 Impact factor: 8.311